Barclays Raises Pfizer Citing Strong Lipitor Revenue

Oct. 20 (Bloomberg) -- Barclays Capital Inc. raised Pfizer Inc. to ``overweight'' on the prospect of new products coming to market and strong sales of Lipitor, a drug used in lowering blood cholesterol. Included are analysts' calls for ConocoPhillips, Suncor Energy Inc., Best Buy Co Inc., Kraft Foods Inc., Deere & Co., Cisco Systems Inc., Transocean Inc., Intel Corp., Waste Management Inc., Cablevision Systems Corp. and Monster Worldwide Inc.